Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunogenicity after two and three doses of mRNA vaccine in patients with cancer treated with exclusive radiotherapy.
Scoccianti S, Delli Paoli C, Infantino M, Paoletti L, Caini S, Meacci F, Russo S, Esposito M, Fondelli S, Grilli Leonulli B, Grossi V, Barca R, Alpi P, Furlan F, Perna M, Pino MS, Martella F, Manfredi M, Stefanacci M, Bassetti A, Casprini P, Fioretto L. Scoccianti S, et al. Among authors: meacci f. Int Immunopharmacol. 2023 Sep;122:110460. doi: 10.1016/j.intimp.2023.110460. Epub 2023 Jun 29. Int Immunopharmacol. 2023. PMID: 37392566
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group.
Borghetti P, Bonù ML, Giubbolini R, Levra NG, Mazzola R, Perna M, Visani L, Meacci F, Taraborrelli M, Triggiani L, Franceschini D, Greco C, Bruni A, Magrini SM, Scotti V. Borghetti P, et al. Among authors: meacci f. Radiol Med. 2019 Jul;124(7):662-670. doi: 10.1007/s11547-019-00999-w. Epub 2019 Feb 15. Radiol Med. 2019. PMID: 30771218
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer.
Meattini I, Francolini G, Scotti V, De Luca Cardillo C, Cappelli S, Meacci F, Furfaro IF, Muntoni C, Scoccianti S, Detti B, Mangoni M, Nori J, Orzalesi L, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: meacci f. Med Oncol. 2015 Mar;32(3):80. doi: 10.1007/s12032-015-0535-9. Epub 2015 Feb 20. Med Oncol. 2015. PMID: 25698536 Clinical Trial.
Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.
Meattini I, Saieva C, Meacci F, Scotti V, De Luca Cardillo C, Desideri I, Baldazzi V, Mangoni M, Scoccianti S, Detti B, Simontacchi G, Nori J, Orzalesi L, Sanchez L, Casella D, Bernini M, Fambrini M, Bianchi S, Livi L. Meattini I, et al. Among authors: meacci f. Future Oncol. 2016 Mar;12(5):625-35. doi: 10.2217/fon.15.357. Epub 2016 Feb 3. Future Oncol. 2016. PMID: 26837239
Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
Livi L, Meattini I, Franceschini D, Saieva C, Meacci F, Marrazzo L, Gerlain E, Desideri I, Scotti V, Nori J, Sanchez LJ, Orzalesi L, Bonomo P, Greto D, Bianchi S, Biti G. Livi L, et al. Among authors: meacci f. Radiother Oncol. 2013 Aug;108(2):273-8. doi: 10.1016/j.radonc.2013.02.009. Epub 2013 Mar 13. Radiother Oncol. 2013. PMID: 23490271
Organs at risk in the brain and their dose-constraints in adults and in children: a radiation oncologist's guide for delineation in everyday practice.
Scoccianti S, Detti B, Gadda D, Greto D, Furfaro I, Meacci F, Simontacchi G, Di Brina L, Bonomo P, Giacomelli I, Meattini I, Mangoni M, Cappelli S, Cassani S, Talamonti C, Bordi L, Livi L. Scoccianti S, et al. Among authors: meacci f. Radiother Oncol. 2015 Feb;114(2):230-8. doi: 10.1016/j.radonc.2015.01.016. Epub 2015 Feb 17. Radiother Oncol. 2015. PMID: 25701297
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
Meattini I, Saieva C, Miccinesi G, Desideri I, Francolini G, Scotti V, Marrazzo L, Pallotta S, Meacci F, Muntoni C, Bendinelli B, Sanchez LJ, Bernini M, Orzalesi L, Nori J, Bianchi S, Livi L. Meattini I, et al. Among authors: meacci f. Eur J Cancer. 2017 May;76:17-26. doi: 10.1016/j.ejca.2017.01.023. Epub 2017 Mar 3. Eur J Cancer. 2017. PMID: 28262584 Clinical Trial.
72 results